Medifast (MED) Enterprise Value (2016 - 2025)
Medifast (MED) has disclosed Enterprise Value for 16 consecutive years, with -$61.0 million as the latest value for Q2 2025.
- For the quarter ending Q2 2025, Enterprise Value changed N/A year-over-year to -$61.0 million, compared with a TTM value of -$133.9 million through Dec 2025, up 17.55%, and an annual FY2024 reading of -$162.3 million, down 191.98% over the prior year.
- Enterprise Value was -$61.0 million for Q2 2025 at Medifast, up from -$72.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$45.0 million in Q3 2023 and bottomed at -$212.9 million in Q1 2021.
- Average Enterprise Value over 5 years is -$114.6 million, with a median of -$113.8 million recorded in 2021.
- The sharpest move saw Enterprise Value soared 56.4% in 2022, then plummeted 191.98% in 2024.
- Year by year, Enterprise Value stood at -$109.5 million in 2021, then grew by 19.95% to -$87.7 million in 2022, then surged by 36.59% to -$55.6 million in 2023, then crashed by 191.98% to -$162.3 million in 2024, then soared by 62.44% to -$61.0 million in 2025.
- Business Quant data shows Enterprise Value for MED at -$61.0 million in Q2 2025, -$72.9 million in Q1 2025, and -$162.3 million in Q4 2024.